The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1247-1258

  Hemby, Scott E ^a,b   Smith, James E ^a   Dworkin, Steven I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; ETICLOPRIDE; NALTREXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG MIXTURE; DRUG RESPONSE; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; COCAINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EATING; HEROIN; MALE; NALTREXONE; RATS; RATS, INBRED F344; RECEPTORS, OPIOID; SALICYLAMIDES;

EID: 0030436864     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. ANDO, K. AND YANAGITA, T.: The discriminative stimulus properties of intravenously administered cocaine in rhesus monkeys. In Stimulus Properties of Drugs: Ten Years of Progress, ed. by F. C. Colpaert and J. S. Rosecrans, pp. 125-136, Elsevier, Amsterdam, 1978.
2. BERGMAN, J., KAMIEN, J. B. AND SPEALMAN, R. D.: Antagonism of cocaine self-administration by selective D1 and D2 antagonists. Behav. Pharmacol. 1: 355-3363, 1990.
3. BRITTON, D. R., CURZON, P., MACKENZIE, R. G., KEBABLAN, J. W., WILLIAMS, J. E. G. AND KERKMAN, D.: Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39: 911-915, 1991.
4. BROWN, E. E., FINLAY, J. M., WONG, J. T. F., DAMSMA, G. AND FIBIGER, H. C.: Behavioral and neurochemical interactions between cocaine and buprenorphine: Implications for the pharmacotherapy of cocaine abuse. J. Pharmacol. Exp. Ther. 256: 119-126, 1991.
5. BROWN, Z. W., AMIT, Z. AND WEEKS, J. R.: Simple flow-thru swivel for infusions into unrestrained animals. Pharmacol. Biochem. Behav. 5: 363-365, 1976.
6. CAINE, S. B. AND KOOB, G. F.: Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270: 209-218, 1994.
7. CARBONI, E., IMPERATO, A., PEREZZANI, L. AND DI CHIARA, G.: Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rata. Neuroscience 28: 653-661, 1989.
8. CARROLL, M. E., LAC, S. T., WALKER, M. J., KRAGH, R. AND NEWMAN, T.: Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation. J. Pharmacol. Exp. Ther. 238: 1-7, 1986.
9. CARROLL, M. E. AND LAC, S. T.: Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology 110:5-12, 1992.
10. COLPAERT, F. C., NIEMEGEERS, C. J. E. AND JANSEN, P. A. J.: Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol. Biochem. Behav. 10: 535-546, 1979.
11. CORRIGALL, W. A.: Heroin self-administration: Effects of antagonist treatment in lateral hypothalamus. Pharmacol. Biochem. Behav. 27:693-700, 1987.
12. CORRIGALL, W. A. AND COEN, K. M.: Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol. Biochem. Behav. 39: 799-802, 1991a.
13. CORRIGALL, W. A. AND COEN, K. M.: Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104: 167-170, 1991b.
14. CORRIGALL, W. A. AND VACCARINO, F. J.: Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. Pharmacol. Biochem. Behav. 30: 443-450, 1988.
15. DAI, S., CORRIGALL, W. A., COEN, K. M. AND KALANT, H.: Heroin self-administration by rats: Influence of dose and physical dependence. Pharmacol. Biochem. Behav. 32: 1009-1015, 1989.
16. DE WIT, H. AND WISE, R. A.: Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine and phenoxybenzamine. Can. J. Psychol. 31: 195-203, 1977.
17. Di CHIARA, G. AND IMPERATO, A.: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85: 5274-5278, 1988a.
18. Di CHIARA, G. AND IMPERATO, A.: Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 24: 1067-1080, 1988b.
19. DWORKIN, S. I. AND BRANCH, M. N.: Behavioral effects of morphine and naloxone following chronic morphine administration. Psychopharmacology 77: 322-326, 1982.
20. DYKSTRA, L. A., DOTY, P., JOHNSON, A. B. AND PICKER, M. J.: Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend. 30: 227-234, 1992.
21. ELLINWOOD, E. H., JR., EIBERGEN, R. D. AND KILBEY M. M.: Stimulants: Interactions with clinically relevant drugs. Ann NY Acad. Sci. 281: 393-408, 1976.
22. EMMETT-OGLESEY, M. W. AND LANE, J. D.: Tolerance to the reinforcing effects of cocaine. Behav. Pharmacol. 3: 193-200, 1992.
23. ETTENBERG, A., PETTIT, H. O., BLOOM, F. E. AND KOOB, G. F.: Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems. Psychopharmacology 78: 204-209, 1982.
24. FOLTIN, R. W. AND FISCHMAN, M. W.: The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J. Pharmacol. Exp. Ther. 261: 623-632, 1992.
25. GERBER, G. J. AND WISE, R. A.: Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: A variable dose paradigm. Pharmacol. Biochem. Behav. 32: 527-531, 1989.
26. GLICK, S. D., HINDS, P. A. AND CAHLSON, J. N.: Food deprivation and stimulant self-administration in rats: Differences between cocaine and d-amphetamine. Psychopharmacology 9:372-374, 1987.
27. GREBERMAN, S. B. AND WADA, K.: Social and legal factors related to drug abuse in the United States and Japan. Public Health Rep. 109: 731-737, 1994.
28. HAMMER, R. J.: Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3: 55-60, 1989.
29. HEMBY, S. E.: Doctoral Dissertation, Wake Forest University, 1995.
30. HEMBY, S. E., CO, C., REBOUSSIN, D., DAVIES, H. M. L., DWORKIN, S. I. AND SMITH, J. E.: Comparison of a novel tropane analog of cocaine, 2β-propanoyl-3β-(4-tolyl) tropane (PTT) with cocaine HCl in rats: Nucleus accumbens extracellular dopamine concentration and motor activity. J. Pharmacol. Exp. Ther. 273: 656-666,1995a.
31. HEMBY, S. E., DWORKIN, S. I. AND SMITH, J. E.: Extracellular dopamine concentrations in the nucleus accumbens during cocaine, heroin and speedball self-administration. College on Problems of Drug Dependence, 1995b.
32. HEMBY, S. E., MARTIN, T. J., CO, C., DWORKIN, S. I. AND SMITH, J. E.: The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J. Pharmacol. Exp. Ther. 273: 591-598, 1995c.
33. 2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105: 151-156, 1991.
34. HUBNER, C. B., BAIN, G. T. AND KORNETSKY, C.: The combined effect of morphine and d-amphetamine on the threshold for brain stimulation reward. Pharmacol. Biochem. Behav. 28: 311-315, 1987.
35. ITZHAK, Y.: Differential regulation of brain opioid receptors following repeated cocaine administration to guinea pigs. Drug Alcohol Depend. 33: 53-59, 1993.
36. IZENWASSER, S. AND KORNETSKY, C.: The effect of amfonelic acid or nisoxetine in combination with morphine on brain stimulation reward. Pharmacol. Biochem. Behav. 32: 983-986, 1989.
37. JÄRBE, T. U. C.: Cocaine cue in pigeons: Time course studies and generalization to structurally related compounds (norcocaine, WIN 35,428 and 35,065-2) and (+)-amphetamine. Br. J. Pharmacol. 73: 843-852, 1981.
38. KAMIEN, J. B. AND SPEALMAN, R. D.: Modulation of the discriminative stimulus effects of cocaine by buprenorphine. Behav. Pharmacol. 2: 517-520, 1991.
39. KALIVAS, P. W. AND DUFFY, P.: Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5: 48-58, 1990.
40. KOOB, G. F. AND BLOOM, F. E.: Cellular and molecular mechanisms of drug dependence. Science (Wash. DC) 242: 715-723, 1988.
41. KOOB, G. F. AND GOEDERS, N. E.: Neuroanatomical substrates of drug self-administration. In The Neuropharmacological Basis of Reward, ed. by J. M. Liebman and S. J. Cooper, pp. 214-263, Clarendon Press, Oxford, 1989.
42. KOOB, G. F., PETTIT, H. O., ETTENBERG, A. AND BLOOM, F. E.: Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 229: 481-486, 1984.
43. KOOB, G. F., VACCARINO, F. J., ALMARIC, M. AND BLOOM, F. E.: Positive reinforcement properties of drugs: search for neural substrates. In Brain Reward Systems and Abuse, ed. by J. Engel and L. Oreland, pp. 35-50, Raven Press, New York, 1987.
44. KOSTEN, T. R., ROUNSAVILLE, B. J. AND KLEBER, H. D.: A 2.5 year follow-up of cocaine use among treated opioid addicts. Arch. Gen. Psychiatry 44: 281-284, 1987.
45. KOSTEN, T. R., ROUNSAVILLE, B. J., GAWIN, F. H. AND KLEBER, H. D.: Cocaine abuse among opioid addicts: Demographic and diagnostic factors in treatment. Am. J. Drug Alcohol Abuse 12: 1-16, 1986.
46. KUCZENSKI, R., SEGAL, D. S. AND AIZENSTEIN, M. L.: Amphetamine, cocaine, and fencamfamine: Relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11: 2703-2712, 1991.
47. LOH, E, A., FITCH, T., VICKERS, G. AND ROBERTS, D. C. S: Clozapine increases breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav. 42: 559-562, 1992.
48. MALDONADO, R., ROBLEDO, P., CHOVER, A. J., CAINE, S. B. AND KOOB, G. F.: D-1 dopamine receptors in the nulceus accumbens modulate cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 45: 239-242, 1993.
49. MARTIN, T. J., DWORKIN, S. I. AND SMITH, J. E.: Alkylation of mu opioid receptors by β-funaltrexamine in vivo: Comparison of the effects on in situ binding and heroin self-administration. J. Pharmacol. Exp. Ther. 272: 1135-1140, 1995.
50. MCGREGOR, A. AND ROBERTS, D. C. S.: Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res. 624: 245-252, 1993.
51. MELLO, N. K., MENDELSON, J. H., BREE, M. P. AND LUKAS, S. E.: Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science (Wash. DC) 245: 859-862, 1989.
52. MELLO, N. K., MENDELSON, J. H., BREE, M. P. AND LUKAS, S. E.: Buprenorphine and naltrexone effects on cocaine self-administration in rhesus monkeys. J. Pharmacol. Exp. Ther. 254: 926-939, 1990.
53. MELLO, N. K., NEGUS, S. S., LUKAS, S. E., MENDELSON, J. H., SHOLAR, J. W. AND DRIEZE, J.: A primate model of polydrug abuse: Cocaine and heroin combinations. J. Pharmacol. Exp. Ther. 274: 1325-1337, 1995.
54. NEGUS, S. S., HENRIKSEN, S. J., MATTOX, A., PASTERNAK, G. W., PORTOGHESE, P. S., TAKEMORI, A. E., WEINGER, M. B. AND KOOB, G. F.: Effects of antagonists selective of mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 265:1245-1252, 1993.
55. NETER, J., WASSERMAN, W. AND KUTNER, M. J.: Applied Linear Statistical Models: Regression, Analysis of Variance, and Experimental Designs, 2nd ed., Irwin, Homewood, IL, 1985.
56. PARSONS, L. H., KOOB, G. F. AND WEISS, F.: Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 274: 1182-1191, 1995.
57. PETTIT, H. O. AND JUSTICE, J. B., JR.: Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol. Biochem. Behav. 34: 899-904, 1989.
58. PETTIT, H. O. AND JUSTICE, J. B., JR.: Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 539: 94-102, 1991.
59. PHILLIPS, G. D., HOWES, S. R., WHITELAW, R. B., ROBBINS, T. W. AND EVERITT, B. J.: Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: Impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists. Psychophamacology 116: 419-429, 1994.
60. PICKENS, R., MEISCH, R. A. AND THOMPSON, T.: Drug self-administration: An analysis of the reinforcing effects of drugs. In Handbook of Peychopharmacology, ed. by S. D. Iversen and S. H. Snyder, vol. 12, pp. 1-37, Plenum Press, New York, 1978.
61. PICKENS, R. AND THOMPSON, T.: Characteristics of stimulant drug reinforcement. In Stimulus Properties of Drugs, ed. by T. Thompson and R. Pickens, pp. 177-192, Plenum Press, New York, 1971.
62. PICKENS, R. AND THOMPSON, T.: Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed ratio size. J. Pharmacol. Exp. Ther. 161: 122-129, 1968.
63. POLLACK, M. H., BROTMAN, A. W. AND ROSENBAUM, J. F.: Cocaine abuse and treatment. Comp. Psychiatry 30: 31-44, 1989.
64. POTHOS, E., RADA, P., MARK, G. P. AND HOEBEL, B. G.: Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566: 348-350, 1991.
65. PULVIRENTI, L., SWERDLOW, N. R., HUBNER, C. B. AND KOOB G. F.: The role of limbic-accumbens-pallidal circuitry in the activation and reinforcing properties of psychostimulant drugs. In The Mesolimbic Dopamine System: From Motivation to Action, ed. by P. Willner and J. Scheel-Krüger, pp. 131-140, John Wiley and Sons, Chichester, England, 1991.
66. RADA, P., MARK, G. P., POTHOS, E. AND HOEBEL, B. G.: Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats. Neuropharmacology 30: 1133-1136, 1991.
67. RAMSEY, N. F. AND VAN REE, J. M.: Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 40: 807-810, 1991.
68. RICHARDSON, N. R., PIERCEY, M. F., SVENNSON, K., COLLINS, R. J., MYERS, J. E. AND ROBERTS, D. C. S.: Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ76. Brain Res. 619: 15-21, 1993.
69. ROBERTS, D. C. S. AND VICKERS, G.: The effects of haloperidol on cocaine self-administration is augmented with repeated administrations. Psychopharmacology 93: 526-528, 1987.
70. ROBERTS, D. C. S. AND VICKERS, G.: Atypical neuroleptics increase self-administration of cocaine: An evaluation of a behavioural screen for anti-psychotic activity. Psychopharmacology 82: 135-139, 1984
71. ROSEN, M. I. AND KOSTEN, T. R.: Buprenorphine: Beyond methadone? Hosp. Community Psychiatry 42: 347-349, 1991.
72. SCHENK, S., VALADEZ, A., MCNAMAHA, C., HOSUE, D. T., HIGLEY, D., BANKSON, M. G., GIBBS, S. AND HORGER, B. A.: Development and expression of sensitization to cocaine's reinforcing properties: Role of NMDA receptors. Psychopharmacology 111: 332-338, 1993.
73. SCHUSTER, C. R. AND THOMPSON, T.: Self-administration of and behavioral dependence on drugs. Annu. Rev. Pharmacol. 9: 483-502, 1969.
74. SCHÜTZ, C. G., VLAHOV, D., ANTHONY, J. C. AND GRAHAM, N. M. H.: Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J. Clin. Epidemiol. 47: 191-195, 1994.
75. SPANAGEL, R., HERZ, A. AND SHIPPENBERG, T. S.: Identification of the opioid receptor types mediating β-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 190: 177-184, 1990a.
76. SPANAGEL, R., HERZ, A. AND SHIPPENBERG, T. S.: The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study. J. Neurochem. 55: 1734-1740, 1990b.
77. SPEALMAN, R. D.: Use of cocaine-discrimination techniques or preclinical evaluation of candidate therapeutics for cocaine dependence. In Problems of Drug Dependence 1991, ed. by L. S. Harris, pp. 175-179, NIDA Research Monograph 119, U.S. Government Printing Office, Washington DC, 1992.
78. SPEALMAN, R. D. AND BERGMAN, J.: Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Ther. 261: 607-615, 1992.
79. SPEALMAN, R. D., MADRAS, B. K. AND BEROMAN, J.: Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J. Pharmacol. Exp. Ther. 251: 142-149, 1989.
80. STRETCH, R.: Discrete-trial control of cocaine self-injection behaviour in squirrel monkeys: Effects of morphine, naloxone and chlorpromazine. Can. J. Physiol. Pharmacol. 55: 778-790, 1977.
81. TUTTON, C. S. AND CRAYTON, J. W.: Current pharmacotherapies for cocaine abuse: A review. J. Addict. Diseases 12: 109-127, 1993.
82. UNTERWALD, E. M., HORNE-KING, J. AND KREEK, M. J.: Chronic cocaine alters brain mu opioid receptors. Brain Res. 584: 314-318, 1992.
83. VACCARINO, F. J., BLOOM, F. E. AND KOOB, G. F.: Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86: 37-42,1985a.
84. VACCARINO, F. J., PETTIT, H. O., BLOOM, F. E. AND KOOB, G. F.: Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat. Pharmacol. Biochem. Behav. 23: 495-498, 1985b.
85. VAN REE, J. M. AND RAMSEY, N.: The dopamine hypothesis of opiate reward challenged. Eur. J. Pharmacol. 134: 239-243, 1987.
86. WEEKS, J. R.: Experimental morphine addiction: Methods for automatic intravenous injections in unrestrained rats. Science 138: 143-144, 1962.
87. WEISS, F., HURD, Y. L., UNGERSTEDT, U., MARKOU, A., PLOTSKY, P. M. AND KOOB, G. F.: Neurochemical correlates of cocaine and ethanol self-administration. Ann. NY Acad. Sci. 654: 220-241, 1992.
88. WENGER, G. R. AND WRIGHT, D. W.: Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats. Pharmacol. Biochem. Behav. 35: 595-600, 1990.
89. WESSON, D. R. AND SMITH, D. E.: Cocaine: Its use for central nervous system stimulation including recreational and medical uses. In Cocaine: 1977. National Institute on Drug Abuse Monograph 13, ed. by R. C. Petersen and R. C. Stillman, pp. 137-152, U.S. Government Printing Office, Washington, DC, 1977.
90. WIECHMAN, B. E., WOOD, T. E. AND SPRATTO, G. R.: Locomotor activity in morphine-treated rats: Effects of and comparisons between cocaine, procaine and lidocaine. Pharmacol. Biochem. Behav. 15: 425-433, 1981.
91. WILSON, M. C. AND SCHUSTER, C. R.: The effects of stimulants and depressants on cocaine self-administration behavior in the rhesus monkey. Psychopharmacologia 31: 291-304, 1973.
92. WINGER, G., SKJOLDAGER, P. AND WOODS, J. H.: Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J. Pharmacol. Exp. Ther. 261: 311-317, 1992.
93. WINGER, G.: Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys. Behav. Pharmacol. 5: 141-152, 1994.
94. WISE, R. A. AND BOZARTH, M. A.: A psychomotor stimulant theory of addiction. Psychol. Rev. 94: 469-492, 1987.
95. WOOD, D. M. AND EMMETT-OLGELSBY, M. W.: Characteristics of tolerance, recovery from tolerance, and cross tolerance for cocaine used as a discriminative stimulus. J. Pharmacol. Exp. Ther. 237: 120-125, 1986.
96. WOODS, J. H. AND SCHUSTER, C. R.: Opiates as reinforcing stimuli. In Stimulus Properties of Drugs, ed. by T. Thompson and R. A. Pickens, pp. 163-175, Appleton Century Crofts, New York, 1971.
97. 2 antagonist on behavior maintained by cocaine or food. Pharmacol. Biochem. Behav. 32: 691-698, 1989.